Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Neo-Bladder Augment for Spina Bifida
NCT00419120Phase 2Terminated
- Sponsor
- Tengion, Inc.
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous neobladder construct in neurogenic bladder, sponsored by Tengion, Inc. Primary endpoint: Number of Responders as Assessed by Compliance at 12 months. Started Dec 2006; status: terminated.
02
Drugs
autologous neobladder construct
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT00419120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419120.